Kinase inhibition has emerged as the preeminent point of intervention for developing novel anti-cancer therapeutics and research tool compounds to dissect signaling pathways. In this proposal, we focus on redox- sensitive kinases and the development of inhibitors that target the oxidized form of these proteins, which are prevalent in many human cancers.
In Aim 1, we identify chemical warheads that target cysteine oxidation species.
In Aim 2, we develop molecules that target oxidized tyrosine kinases and evaluate their effectiveness in vitro and cancer cell-based assays.
In Aim 3, we evaluate the therapeutic efficacy of new kinase inhibitors. Inhibitors identified in this study will serve as vital tools for dissecting mechanistic details of kinase redox regulation and the relationship between oxidative stress/aberrant kinase activity in cancer. Furthermore, these collective aims will create a foundation for the development of an entirely new class of anti-cancer drugs.

Public Health Relevance

Oxidative stress and deregulation of protein kinase activity play significant roles in the development and progression of cancer. Successful covalent inhibitors have been developed that interact with the amino acids cysteine or lysine in proteins, however off-target interactions remain a significant problem. Here, we propose a new chemical strategy to make inhibitors that retains the specific advantages gained through covalent targeting and decrease the potential for off-target activity. These new inhibitors will provide an important starting point for the development of new anti-cancer drugs.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Drug Discovery and Molecular Pharmacology Study Section (DMP)
Program Officer
Knowlton, John R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Florida
United States
Zip Code
Akter, Salma; Fu, Ling; Jung, Youngeun et al. (2018) Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat Chem Biol 14:995-1004
Fu, Ling; Liu, Keke; Ferreira, Renan B et al. (2018) Proteome-Wide Analysis of Cysteine S-Sulfenylation Using a Benzothiazine-Based Probe. Curr Protoc Protein Sci :e76
Gupta, Vinayak; Yang, Jing; Liebler, Daniel C et al. (2017) Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles. J Am Chem Soc 139:5588-5595
Garcia, Francisco J; Carroll, Kate S (2016) An immunochemical approach to detect oxidized protein tyrosine phosphatases using a selective C-nucleophile tag. Mol Biosyst 12:1790-8
Gupta, Vinayak; Paritala, Hanumantharao; Carroll, Kate S (2016) Reactivity, Selectivity, and Stability in Sulfenic Acid Detection: A Comparative Study of Nucleophilic and Electrophilic Probes. Bioconjug Chem 27:1411-8
Yang, Jing; Carroll, Kate S; Liebler, Daniel C (2016) The Expanding Landscape of the Thiol Redox Proteome. Mol Cell Proteomics 15:1-11
Gupta, Vinayak; Carroll, Kate S (2016) Rational design of reversible and irreversible cysteine sulfenic acid-targeted linear C-nucleophiles. Chem Commun (Camb) 52:3414-7
Gupta, Vinayak; Carroll, Kate S (2016) Profiling the Reactivity of Cyclic C-Nucleophiles towards Electrophilic Sulfur in Cysteine Sulfenic Acid. Chem Sci 7:400-415
Truong, Thu H; Ung, Peter Man-Un; Palde, Prakash B et al. (2016) Molecular Basis for Redox Activation of Epidermal Growth Factor Receptor Kinase. Cell Chem Biol 23:837-848
Brewer, Thomas F; Garcia, Francisco J; Onak, Carl S et al. (2015) Chemical approaches to discovery and study of sources and targets of hydrogen peroxide redox signaling through NADPH oxidase proteins. Annu Rev Biochem 84:765-90

Showing the most recent 10 out of 28 publications